Literature DB >> 10854844

Substance P induces tumor necrosis factor-alpha release from human skin via mitogen-activated protein kinase.

T Okabe1, M Hide, O Koro, S Yamamoto.   

Abstract

Substance P plays an important role in neurogenic inflammation with granulocyte infiltration. To investigate cytokines involved in the substance P-induced inflammation and the mechanism of cell activation, we studied the release of TNF (tumor necrosis factor)-alpha and histamine from human skin slices in response to substance P and antigen. Substance P induced the release of histamine and TNF-alpha in a dose-dependent manner at concentrations from 0.8 to 100 microM. PD 098059 (2'-amino-3'-methoxyflavone) selectively inhibited the release of TNF-alpha, but not the release of histamine induced by either substance P or antigen. SB 203580 ([4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-++ +imida zole]) slightly inhibited TNF-alpha release induced by antigen, but not that induced by substance P, and slightly enhanced histamine release induced by either stimulation. The release of TNF-alpha in response to either stimulation was inhibited by 1 nM-1 microM dexamethasone, but histamine release was not affected. These results suggest that substance P, in addition to antigen, induced TNF-alpha release from human skin by a mitogen-activated protein (MAP) kinase, predominantly extracellular signaling-regulated protein kinase (ERK)-dependent, and dexamethasone-sensitive pathway, which is separate from that for histamine release from mast cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854844     DOI: 10.1016/s0014-2999(00)00304-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals.

Authors:  T Okabe; M Hide; O Koro; N Nimi; S Yamamoto
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways.

Authors:  Xiaoyou Shi; Liping Wang; J David Clark; Wade S Kingery
Journal:  Regul Pept       Date:  2013-08-17

3.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

4.  SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.

Authors:  Alexandra Taracanova; Mihail Alevizos; Anna Karagkouni; Zuiy Weng; Errol Norwitz; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

5.  Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis.

Authors:  Kazunori Fujino; Yoji Takami; Sebastian G de la Fuente; Kirk A Ludwig; Christopher R Mantyh
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

6.  The role of PAK1 in the sensitivity of kidney epithelial cells to ischemia-like conditions.

Authors:  Evan R Zynda; Mitchell H Maloy; Eugene S Kandel
Journal:  Cell Cycle       Date:  2019-02-11       Impact factor: 4.534

7.  Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats.

Authors:  N Kihara; S G de la Fuente; K Fujino; T Takahashi; T N Pappas; C R Mantyh
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

8.  [Stress and the molecular basis of psychosomatics].

Authors:  E M J Peters
Journal:  Hautarzt       Date:  2013-06       Impact factor: 0.751

9.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Authors:  Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2016-01-13       Impact factor: 4.030

10.  Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.

Authors:  Kate Marie Lewis; Renée Jade Turner; Robert Vink
Journal:  Int J Inflam       Date:  2013-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.